Wave Life Sciences WVE
NASDAQ WVE
$4.84 +0.14 (+2.87%)
As of: Sep 4, 2026 · 2:36 PM EDT

Wave Life Sciences (WVE) Other Non Operating Income (2014 - 2026)

Wave Life Sciences' (WVE) quarterly Other Non Operating Income came in at -$275000.0 in Q2 2026, down 235.37% YoY from $203153.2 in Q2 2025, and down 243.75% on a QoQ basis from -$80000.0 in Q1 2026.

Analysis

Wave Life Sciences (WVE) Other Non Operating Income (2014 - 2026) Analysis & Trends

Wave Life Sciences (WVE) has 13 years of Other Non Operating Income data on file, last reported at -$275000.0 in Q2 2026.

  • Quarterly Other Non Operating Income fell 235.37% year-over-year to -$275000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $203000.0 (down 92.89% YoY) and the FY2025 annual result came in at $527000.0, down 83.69% from the prior year.
  • Other Non Operating Income eased to -$275000.0 in Q2 2026, from -$80000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.5 million in Q4 2024 to a low of -$701000.0 in Q3 2022.
  • A 5-year average of $293833.3 and a median of $202500.0 in 2023 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2024 — Other Non Operating Income soared 337.8% — and 2025, when it plunged 355.56%.
  • Tracing WVE's Other Non Operating Income over 5 years: stood at -$290000.0 in 2022, then soared by 300.69% to $582000.0 in 2023, then surged by 337.8% to $2.5 million in 2024, then tumbled by 90.82% to $234000.0 in 2025, then plunged by 217.52% to -$275000.0 in 2026.
  • The last three Other Non Operating Income figures came in at -$275000.0 (Q2 2026), -$80000.0 (Q1 2026), and $234000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Wave Life Sciences 987.40 Mn 619.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -275,000.00
Mar 31, 2026 -80,000.00
Dec 31, 2025 234,000.00
Sep 30, 2025 324,000.00
Jun 30, 2025 -82,000.00
Mar 31, 2025 51,000.00
Dec 31, 2024 2.55 Mn
Sep 30, 2024 337,000.00
Jun 30, 2024 -18,000.00
Mar 31, 2024 365,000.00
Dec 31, 2023 582,000.00
Sep 30, 2023 171,000.00
Jun 30, 2023 118,000.00
Mar 31, 2023 1.01 Mn
Dec 31, 2022 -290,000.00
Sep 30, 2022 -701,000.00
Jun 30, 2022 744,000.00
Mar 31, 2022 254,000.00
Dec 31, 2021 1.12 Mn
Sep 30, 2021 1.37 Mn